Heparin Is Required for Cell-Free Binding of Basic Fibroblast Growth Factor to a Soluble Receptor and for Mitogenesis in Whole Cells

References

• Baird, A., D. Schubert, N. Ling, and R. Guillemin. 1988. Receptor- and heparin-binding domains of basic fibroblast growth factor. Proc. Natl. Acad. Sci. USA 85:2324–2328.
   PubMed Web of Science ®Google Scholar
• Bashkin, P., S. Doctrow, M. Klagsbrun, C. M. Svahn, J. Folkman, and I. Vlodavsky. 1989. Basic fibroblast growth factor binds to subendothelial extracellular matrix and is released by heparitinase and heparin-like molecules. Biochemistry 28:1737–1743.
   PubMed Web of Science ®Google Scholar
• Berger, J., J. Hauber, R. Hauber, R. Geiger, and B. R. Cullen. 1988. Secreted placental alkaline phosphatase: a powerful new quantitative indicator of gene expression in eukaryotic cells. Gene 66:1–10.
   PubMed Web of Science ®Google Scholar
• Burrus, L. W., and B. B. Olwin. 1989. Isolation of a receptor for acidic and basic fibroblast growth factor from embryonic chick. J. Biol. Chem. 264:18647–18653.
   PubMed Web of Science ®Google Scholar
• Collins, M. K. L., J. Downward, A. Miyajima, K. Maruyama, K.-L. Arai, and R. C. Mulligan. 1988. Transfer of functional EGF receptors to an IL3-dependent cell line. J. Cell. Physiol. 137:293–298.
   PubMedGoogle Scholar
• Cook, P. W., P. A. Mattox, W. W. Keeble, M. R. Pittelkow, G. D. Plowman, M. Shoyab, J. P. Adelman, and G. D. Shipley. 1991. A heparin sulfate-regulated human keratinocyte autocrine factor is similar or identical to amphiregulin. Mol. Cell. Biol. 11:2547–2557.
   PubMed Web of Science ®Google Scholar
• D'Andrea, A. D., A. Yoshimura, H. Youssoufian, L. I. Zon, J.-W. Koo, and H. F. Lodish. 1991. The cytoplasmic region of the erythropoietin receptor contains nonoverlapping positive and negative growth-regulatory domains. Mol. Cell. Biol. 11:1980–1987.
   PubMed Web of Science ®Google Scholar
• Eriksson, A. E., L. S. Cousens, L. H. Weaver, and B. W. Matthews. 1991. Three-dimensional structure of human basic fibroblast growth factor. Proc. Natl. Acad. Sci. 88:3441–3445.
   PubMed Web of Science ®Google Scholar
• Flanagan, J. G., and P. Leder. 1990. The kit ligand: a cell surface molecule altered in steel mutant fibroblasts. Cell 63:185–194.
   PubMed Web of Science ®Google Scholar
• Folkman, J., R. Langer, R. J. Linhardt, C. Haudenschild, and S. Taylor. 1983. Angiogenesis inhibition and tumor regression caused by heparin or a heparin fragment in the presence of cortisone. Science 221:719–725.
   PubMed Web of Science ®Google Scholar
• Fox, G. M., S. G. Schiffer, M. F. Rohde, L. B. Tsai, A. R. Banks, and T. Arakawa. 1988. Production, biological activity, and structure of recombinant basic fibroblast growth factor and an analog with cysteine replaced by serine. J. Biol. Chem. 34:18452–18458.
   Google Scholar
• Gallagher, J. T., M. Lyon, and W. P. Steward. 1986. Structure and function of heparan sulfate proteoglycans. Biochem. J. 236:313–325.
   PubMed Web of Science ®Google Scholar
• Gallagher, J. T., and A. Walker. 1985. Molecular distinctions between heparan sulfate and heparin. Biochem. J. 230:665–674.
   PubMed Web of Science ®Google Scholar
• Gospodarowicz, D., N. Ferrara, L. Schweigerer, and G. Neufeld. 1987. Structural characterization and biological functions of fibroblast growth factor. Endocr. Rev. 8:95–114.
   PubMed Web of Science ®Google Scholar
• Hatakeyama, M., H. Mori, T. Doi, and T. Taniguchi. 1989. A restricted cytoplasmic region of IL-2 receptor beta chain is essential for growth factor signal transduction but not for ligand binding and internalization. Cell 59:837–845.
   PubMed Web of Science ®Google Scholar
• Higashiyama, S., J. A. Abraham, J. Miller, J. C. Fiddes, and M. Klagsbrun. 1991. A heparin-binding growth factor secreted by macrophage-like cells that is related to EGF. Science 251:936–939.
   PubMed Web of Science ®Google Scholar
• Karasuyama, H., and F. Melchers. 1988. Establishment of mouse cell lines which constitutively secrete large quantities of interleukin 2, 3, 4 or 5, using modified cDNA expression vectors. Eur. J. Immunol. 18:97–104.
   PubMed Web of Science ®Google Scholar
• Kiefer, M. C., J. C. Stephans, K. Crawford, K. Okino, and P. J. Barr. 1990. Ligand-affinity cloning and structure of a cell surface heparan sulfate proteoglycan that binds basic fibroblast growth factor. Proc. Natl. Acad. Sci. USA 87:6985–6989.
   PubMed Web of Science ®Google Scholar
• Kitamura, T., K. Hayashida, K. Sakamaki, T. Yokota, K.-L. Arai, and A. Miyajima. 1991. Reconstitution of functional receptors for human granulocyte/macrophage colony-stimulating factor (GM-CSF): evidence that the protein encoded by the AIC2B cDNA is a subunit of the murine GM-CSF receptor. Proc. Natl. Acad. Sci. U.S.A. 88:5082–5086.
   PubMed Web of Science ®Google Scholar
• Klagsbrun, M. 1990. The affinity of fibroblast growth factor (FGFs) for heparin; FGF-heparin sulfate interactions in cells and extracellular matrix. Curr. Opin. Cell Biol. 222:857–863.
   Google Scholar
• Lax, L., A. K. Mitras, C. Ravera, D. R. Hurwitz, M. Rubinstein, A. Ullrich, R. Stroud, and J. Schlessinger. 1991. Epidermal growth factor (EGF) induces oligomerization of soluble, extracellular, ligand-binding domain of EGF receptor. J. Biol. Chem. 266:13828–13833.
   PubMed Web of Science ®Google Scholar
• Limbird, L. E. 1986. Cell surface receptors: a short course on theory and methods, p. 51–96. Martinus Nijhoff Publishers, Boston.
   Google Scholar
• Lindahl, U. 1989. Biosynthesis of heparin and related polysaccharides, p. 159–189. In D. A. Land and U. Lindahl (ed.), Heparin: chemical and biological properties, clinical applications. Edward Arnold, London.
   Google Scholar
• Mathey-Prevot, B., G. Nabel, R. Palacios, and D. Baltimore. 1986. Abelson virus abrogation of interleukin-3 dependence in a lymphoid cell line. Mol. Cell. Biol. 6:4133–4135.
   PubMed Web of Science ®Google Scholar
• Moscatelli, D. 1987. High and low affinity binding sites for basic fibroblast growth factor on cultured cells: absence of a role for low affinity binding in the stimulation of plasminogen activator production by bovine capillary endothelial cells. J. Cell. Physiol. 131:123–130.
   PubMed Web of Science ®Google Scholar
• Moscatelli, D. 1988. Metabolism of receptor-bound and matrix bound basic fibroblast growth factor by bovine capillary endothelial cells. J. Cell Biol. 107:753–759.
   PubMed Web of Science ®Google Scholar
• Nader, H. B., C. P. Dietrich, V. Buonassi, and P. Colbrun. 1987. Heparin sequences in the heparan sulfate chains of an endothelial cell proteoglycan. Proc. Natl. Acad. Sci. USA 84:3565–3569.
   PubMedGoogle Scholar
• Palacios, R., and M. Steinmetz. 1985. IL3-dependent mouse clones that express B-220 surface antigen, contain Ig genes in germ-line configuration, and generate B lymphocytes in vivo. Cell 41:727–734.
   PubMed Web of Science ®Google Scholar
• Rapraeger, A. C., A. Krufka, and B. B. Olwin. 1991. Requirement of heparan sulfate for bFGF-mediated fibroblast growth and myoblast differentiation. Science 252:1705–1708.
   PubMed Web of Science ®Google Scholar
• Roberts, R., J. Gallagher, E. Spooncer, T. D. Allen, F. Bloomfield, and T. M. Dexter. 1988. Heparan sulphate bound growth factors: a mechanism for stromal cell mediated haemopoiesis. Nature (London) 332:376–378.
   PubMed Web of Science ®Google Scholar
• Ruoslahti, E. 1989. Proteoglycans in cell regulation. J. Biol. Chem. 264:13369–13372.
   PubMed Web of Science ®Google Scholar
• Ruoslahti, E., and Y. Yamaguchi. 1991. Proteoglycans as modulators of growth factor activities. Cell 64:867–869.
   PubMed Web of Science ®Google Scholar
• Sanderson, R. Unpublished data.
   Google Scholar
• Sudhalter, J., J. Folkman, C. M. Svahn, K. Bergendal, and P. A. D'Amore. 1989. Importance of size, sulfation, and anticoagulant activity in the potentiation of acidic fibroblast growth factor by heparin. J. Biol. Chem. 264:6892–6897.
   PubMed Web of Science ®Google Scholar
• Turnbull, J. E., and J. T. Gallagher. 1991. Distribution of iduronate 2-sulphate residues in heparan sulfate. Evidence for an ordered polymeric structure. Biochem. J. 273:553–559.
   PubMed Web of Science ®Google Scholar
• Ullrich, A., and J. Schlessinger. 1990. Signal transduction by receptors with tyrosine kinase activity. Cell 61:203–212.
   PubMed Web of Science ®Google Scholar
• Vlodavsky, I., J. Folkman, R. Sullivan, R. Fridman, R. Ishai-Michaeli, J. Sasse, and M. Klagsbrun. 1987. Endothelial cell- derived basic fibroblast growth factor: synthesis and deposition into subendothelial extracellular matrix. Proc. Natl. Acad. Sci. USA 84:2292–2296.
   PubMed Web of Science ®Google Scholar
• Wright, T. C., J. J. Castellot, J. R. Diamond, and M. J. Karnovsky. 1989. Regulation of cellular proliferation by heparin and heparan sulphate, p. 295–316. In D. A. Land and U. Lindahl (ed.), Heparin: chemical and biological properties, clinical applications. Edward Arnold, London.
   Google Scholar
• Yayon, A., M. Klagsbrun, J. D. Esko, P. Leder, and D. M. Ornitz. 1991. Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor. Cell 64:841–848.
   PubMed Web of Science ®Google Scholar